Article
The Future of "Omics" in Hypertension.
The Canadian journal of cardiology - 1 May 2017
Currie Gemma, Delles Christian
Abstract excerpt
Despite decades of research and clinical practice, the pathogenesis of hypertension remains incompletely understood, and blood pressure is often suboptimally controlled. "Omics" technologies allow the description of a large number of molecular features and have the potential to identify new factors that contribute to blood pressure regulation and how they interact. In this review, we focus on the potential of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
